Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lente Kroon, MD
CONTACT
Dieta Brandsma, MD, PhD
CONTACT
Lead
The Netherlands Cancer Institute
This prospective phase II diagnostic feasibility study investigates the diagnostic potential of 68-Gallium PSMA-PET/CT in stereotactic irradiated brain metastases from non-small cell lung cancer, melanoma and breast cancer. Participants will be enrolled in three predefined cohorts per primary tumor type: 1. newly diagnosed brain metastases, 2. definite radiation necrosis, and 3. diagnostic dilemma after radiotherapy. The goals of this study are: 1\. Evaluating PSMA expression using Ga68-PSMA PET/CT in brain metastases of NSCLC, breast cancer and melanoma patients eligible for stereotactic radiotherapy (SRT) or surgery. 2. Evaluating PSMA expression using Ga68-PSMA PET/CT in patients with definite radiation necrosis. 3. Evaluating the use of Ga68-PSMA PET/CT to differentiate progressive brain metastases of NSCLC, breast cancer and/ or melanoma from radiation necrosis by quantifying PSMA activity.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
